Stem cells offer new therapeutic avenues for the repair and replacement of damaged tissues
and organs owing to their self-renewal and multipotent differentiation capabilities. In this …

Research has advanced considerably since the first clinical trial of human mesenchymal
stem cells (MSCs) in the early 1990s. During this period, our understanding of MSC biology …

The objective of this study was to assess whether mesenchymal stem cells (MSCs) therapy
could offer survival advantages for patients with novel coronavirus disease 2019 (COVID …

Lung transplantation is often the only viable treatment option for a patient with end-stage
lung disease. Lung transplant results have improved substantially over time, but ischemia …

Despite the considerable advancements in oncology, cancer remains one of the leading
causes of death worldwide. Drug resistance mechanisms acquired by cancer cells and …

Interstitial lung diseases (ILDs) are a heterogeneous group of pulmonary disorders
characterized by variable degrees of inflammation, interstitial thickening, and fibrosis …

Background Human adipose stromal cells-derived extracellular vesicles (haMSC-EVs) have
been shown to alleviate inflammation in acute lung injury (ALI) animal models. However …

Abstract Background Mesenchymal stromal cells (MSCs) have shown promising therapeutic
options for acute lung injury (ALI) caused by multiple factors. Here, we evaluated the …

Background Traumatic brain injury (TBI) is a significant cause of death and disability, with no
effective neuroprotective drugs currently available for its treatment. Mesenchymal stromal …

The discovery that a population of cells derived from adult tissues had regenerative
properties and could be expanded and utilized therapeutically led to an abundance of …